Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ / shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Net revenues	$ 749,654	$ 762,644	$ 2,322,871	$ 2,258,822
Cost of sales	423,541	483,188	1,332,112	1,429,609
Gross Profit	326,113	279,456	990,759	829,213
Operating expenses:
Research and development	181,224	164,109	475,365	416,519
Selling, general and administrative	538,924	172,788	1,460,233	601,870
Stock based compensation	0	0	0	8,802
Depreciation and amortization	22,137	19,280	66,904	57,247
Total operating expenses	742,285	356,177	2,002,502	1,084,438
Loss from operations	(416,172)	(76,721)	(1,011,743)	(255,225)
Other income (expense):
EIDL Grant	0	0	0	10,000
Forgiveness of Paycheck Protection Program	332,542	0	693,817	(0)
Interest income	655	3,307	2,474	13,023
Interest and finance expenses	(2,418)	(1,261)	(7,587)	(3,798)
Total other income (expense)	330,779	2,046	688,704	19,225
(Loss) before (benefit) for income taxes	(85,393)	(74,675)	(323,039)	(236,000)
(Benefit) for income taxes:
Current	0	(1,800)	(19,818)	(14,300)
Deferred	(13,000)	(5,000)	(163,000)	6,000
Total (benefit) for income taxes	(13,000)	(6,800)	(182,818)	(8,300)
Net (loss)	$ (72,393)	$ (67,875)	$ (140,221)	$ (227,700)
Basic and diluted per common share: (in dollars per share)	$ (0)	$ 0	$ (0)	$ 0
Weighted average shares of common stock outstanding - basic and diluted (in shares)	67,588,504	67,588,504	67,588,504	67,588,504